FDA clears Roche's automated type-specific herpes tests

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection. 

"These are the first automated type-specific herpes tests available for integrated analyzer platforms, which will enable labs to integrate efficient herpes testing into their existing workflow," said Randy Pritchard, vice president of marketing at Roche Diagnostics Corporation. "The approval of the type-specific assays also means healthcare providers now have another tool to give them greater confidence in their diagnosis and overall patient care."

The addition of these tests further expands the company's infectious disease test portfolio for labs of all sizes. Roche currently offers the broadest test menu available on an integrated (chemistry and immunoassay) platform.

Source:

Roche Diagnostics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Roche Diagnostics Limited. (2019, June 20). FDA clears Roche's automated type-specific herpes tests. News-Medical. Retrieved on December 03, 2020 from https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx.

  • MLA

    Roche Diagnostics Limited. "FDA clears Roche's automated type-specific herpes tests". News-Medical. 03 December 2020. <https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx>.

  • Chicago

    Roche Diagnostics Limited. "FDA clears Roche's automated type-specific herpes tests". News-Medical. https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx. (accessed December 03, 2020).

  • Harvard

    Roche Diagnostics Limited. 2019. FDA clears Roche's automated type-specific herpes tests. News-Medical, viewed 03 December 2020, https://www.news-medical.net/news/20120905/FDA-clears-Roches-automated-type-specific-herpes-tests.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test